tickdelta
Sign in
Screener / SEC EDGAR /CIK 0001757898 /10-K filed May 29, 2026, compared with May 29, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
WATDXCMRMDEWSTEINCY
NYSE Health care · Medical Devices

Steris STE

STE quote by TradingView

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 10-K, Item 1

Headquarters
Dublin, L2
CEO
Daniel A. Carestio
Next results
around Feb 3, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2026

Revenue of $5.9B through the costs to a net profit of $782.3M · income statement of the 10-K

19% operating margin
Revenue to Gross profit: $2.6BRevenue to Cost of revenue: $3.3BGross profit to Operating profit: $1.1BGross profit to Operating expenses: $1.5BOperating profit to Net profit: $782.3MOperating profit to Tax & other: $319.5MOperating expenses to R&D: $112.9MOperating expenses to SG&A: $1.4B Revenue: $5.9B REVENUE $5.9B +9% Y/Y Gross profit: $2.6B · 44% margin GROSS PROFIT $2.6B 44% margin · +9% Y/Y Cost of revenue: $3.3B · 56% of revenue COST OF REVENUE $3.3B 56% of revenue Operating profit: $1.1B · 19% margin OPERATING PROFIT $1.1B 19% margin · +27% Y/Y Operating expenses: $1.5B · 26% of revenue OPERATING EXPENSES $1.5B 26% of revenue Net profit: $782.3M · 13% margin NET PROFIT $782.3M 13% margin · +27% Y/Y Tax & other: $319.5M · 5% of revenue TAX & OTHER $319.5M 5% of revenue R&D: $112.9M · 2% of revenue R&D $112.9M 2% of revenue SG&A: $1.4B · 24% of revenue SG&A $1.4B 24% of revenue
Gross profit $2.6B 44% margin · +9% Y/Y
Operating profit $1.1B 19% margin · +27% Y/Y
Net profit $782.3M 13% margin · +27% Y/Y
The full income statement, year by year

STE among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 8.7%, above 61% of 59 peers (their median 7.1%) REVENUE GROWTH 8.7% · above 61% Gross margin: 44.6%, above 28% of 50 peers (their median 65.2%) GROSS MARGIN 44.6% · above 28% Operating margin: 19.0%, above 68% of 50 peers (their median 13.4%) OPERATING MARGIN 19.0% · above 68% Net margin: 13.4%, above 56% of 59 peers (their median 9.5%) NET MARGIN 13.4% · above 56% FCF margin: 15.2%, above 49% of 55 peers (their median 15.8%) FCF MARGIN 15.2% · above 49% Return on capital: 9.0%, above 49% of 41 peers (their median 9.2%) RETURN ON CAPITAL 9.0% · above 49%
STE Peer median Below the median

What changed

10 new risk paragraphs. 10-K filed May 29, 2026 against May 29, 2025.

Risk factors
10 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Accounting checks
11 other checks clear
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
5 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +4.7% vs revenue +8.7% (-4.1 pts)
  • Cash from operations $1.3B vs net income $782.3M (FY ending Mar 31, 2026)
  • Inventory +8.7% vs revenue +8.7% (-0.0 pts)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: Ernst & Young LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Description of Uncertain Tax Positions
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

10 paragraphs in Risk Factors that were not in the 10-K filed May 29, 2025. Quoted as filed.

All 10 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed May 29, 2025 10-K, ITEM 1A
    The introduction and evolution of climate- and sustainability-related laws, regulations and reporting requirements—many of which are not uniform across jurisdictions—can increase the complexity and cost of compliance and heighten our exposure to enforcement actions, litigation and reputational harm. For example, the European Union…
  2. Item 1A · new paragraph · not in the 10-K filed May 29, 2025 10-K, ITEM 1A
    Court of Cook County, Illinois. A claims process regarding confidential settlement agreements is ongoing and subject to final court approval. Furthermore, some claims would be subject to further litigation if certain terms of the applicable settlement agreements are not fulfilled and we exercise our walkaway rights. Please refer to Note…
  3. Item 1A · new paragraph · not in the 10-K filed May 29, 2025 10-K, ITEM 1A
    Similarly, we continue to invest in smart manufacturing to drive structural cost reduction in our facilities, including aligning work to more efficient manufacturing centers, implementing advanced manufacturing capabilities such as digital initiatives, automation and robots, and closing facilities that are not required to meet future…
  4. Item 1A · new paragraph · not in the 10-K filed May 29, 2025 10-K, ITEM 1A
    Likewise, governments and regulatory bodies worldwide are actively developing new laws, regulations and ethical guidelines governing AI use, including the European Union’s Artificial Intelligence Act. Compliance with evolving and potentially inconsistent AI regulations across jurisdictions may be costly and complex. Failure to comply…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2023FY2024FY2025FY2026
Revenue$4.5B$5.1B$5.5B$5.9B
Net income$107.0M$378.2M$614.6M$782.3M
Operating cash flow$756.9M$973.3M$1.1B$1.3B
Free cash flow$395.0M$613.0M$778.0M$972.4M

Revenue, FY2017 to FY2026

Ten fiscal years, each from its own 10-K · XBRL · USD

$5.9B ▲ 8.7% in FY2026

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Every number, year by year

Recent filings

5 filings in the last 30 days · SEC EDGAR

All filings

About the company

Steris, Dublin, L2 · from the 10-K filed May 29, 2026

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services.

Headquarters
Dublin, L2
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
March 31
Last results
Nov 4, 2026
Incorporated in
Ireland

Email alerts

Sources

The 10-K filed May 29, 2026 (open at SEC), compared with the 10-K filed May 29, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/STE/export.csv") into a cell.